← Back to Clinical Trials
RecruitingNCT03848962

Collection and Distribution of Biospecimens for Novel Research Uses

Trial Parameters

ConditionCancer
SponsoriSpecimen Inc
Study TypeOBSERVATIONAL
PhaseN/A
Enrollment10,000
SexALL
Min Age1 Month
Max Age89 Years
Start Date2016-06-30
Completion2025-12-31

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing researchers and educators ("researchers") with annotated biospecimens for use in biomarker discovery and validation; diagnostic test and instrumentation development and validation; therapeutics development; other medical research including the impact that various specimen collection and handling methods and conditions have on research results; and in education such as researcher or physician training (collectively "research").

Eligibility Criteria

Inclusion Criteria: * Individual is developmentally aged 7 years old and above for RUO collections (only) * Individual meets requirements of a current request for research materials from iSpecimen * If a blood collection will be performed as part of the screening process or RUO collection, the individual's health will be assessed by medical staff through medical record review, clinical exam, and/or the review of an updated medical history as provided by the participant * Individual has reviewed and signed a consent form for an RUO specimen collection if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent/guardian or Legally Authorized Representative has reviewed and signed the consent form on their behalf. * Individual has reviewed and signed a consent form for remnant specimen usage in research if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent/guardian or Le

Related Trials